EIT Pharma logo

EIT Pharma

eitpharma.com

EIT Pharma develops therapies for infectious diseases with high unmet needs, including treatments for chronic hepatitis D and acute respiratory infections. It aims to advance therapies for patients who have few treatment options through an efficient drug-development process.

Facts

HQ
Kirkland, WA
Sectors
Biotechnology Research
Employees
6
Founders
Jeffrey Glenn

Is this your organization? Claim it

EIT Pharma, led by ex-Athira CEO Leen Kawas, raises $35M Series A to advance lonafarnib for chronic hepatitis D

Kirkland-based EIT Pharma, led by former Athira CEO Leen Kawas, raised $35 million in an oversubscribed Series A led by Propel Bio Partners to support FDA review, manufacturing and commercial preparations for lonafarnib as an oral treatment candidate for chronic hepatitis D. The FDA accepted EIT Pharma's New Drug Application for lonafarnib on Aug. 11; the drug was acquired from Eiger BioPharmaceuticals' 2024 bankruptcy sale.

Leen Kawas returns as CEO of Kirkland’s EIT Pharma after 2021 Athira exit, to advance lonafarnib

Leen Kawas has returned to operations as CEO of Kirkland-based EIT Pharma after leaving Athira in 2021 and running Propel Bio Partners with investor Richard Kayne; she will lead the small infectious-disease biotech as it advances its lead drug lonafarnib toward data readouts while balancing travel and investment work. The company has about a dozen employees, occupies a coworking space in Kirkland, and expects to need new Seattle-area office space within a year.

Archive: The Long Run: Creating a Life Science Startup (Fundamentals for Startups)

(https://comotion.uw.edu) Originally streamed Friday, February 5th, 2021 from 12-1 pm, this Fundamentals for Startups featured Leen Jawas, CEO of Athira Pharma (https://www.athira.com/about-athira/) presenting: "The Long Run: Creating a Life Science Startup" Dr. Leen Kawas has served as Athira Pharma’s CEO and as a member of the board of directors since January 2014. Previously, Dr. Kawas served as Athira’s vice president. Dr. Kawas serves on multiple boards, including the Washington Governor’s Life Science Advisory Board, Scientific Review Board for the Alzheimer’s Drug Discovery Foundation, and Alzheimer’s Association – Washington Chapter Board. She also served as the co-chair of the International Alzheimer's…

See all 4 stories, episodes and videos about EIT Pharma.

People

  • Leen Kawas Executive, Chief Executive Officer
  • Xue Hua Executive, Chief Development Officer (CDO)

Online